Skip to main content
SpringerLink
Log in

Costs of immune-related AEs vary in patients with melanoma

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. programmed cell death-1 receptor antagonists

  2. programmed cell death-1 receptor antagonists

Reference

  • Mennini FS, et al. Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma. Clinical Drug Investigation : 24 Aug 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0690-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of immune-related AEs vary in patients with melanoma. Reactions Weekly 1717, 5 (2018). https://doi.org/10.1007/s40278-018-51075-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-51075-2

Search

Navigation